Overall, the activation of Nrf2 has been shown to reduce the pathological score of many diseases such as chronic obstructive pulmonary disease (COPD) [304] and sickle cell disease [305], among others. The gene discussed is NFE2L2; the disease is chronic obstructive pulmonary disease.